Key result
Novel de novo ZC4H2 mutation links to Wieacker-Wolff syndrome via altered protein localization.
Why the study?
Wieacker-Wolff syndrome is associated with the ZC4H2 gene, but the underlying pathogenic mechanism remains elusive.
Case Report (n=1)
Female heterozygous carriers of a nonsense mutation resulting in a truncated ZC4H2 protein can develop severe Wieacker-Wolff syndrome.
Alerts clinicians to severe Wieacker-Wolff syndrome in female ZC4H2 nonsense carriers; leaves open broader genotype-phenotype correlations.
BACKGROUND: Wieacker-Wolff syndrome (WWS) is a congenital X-linked neuromuscular disorder, which was firstly reported in 1985. Zinc finger C4H2-type containing (ZC4H2) gene has been found to be associated with the disease pathogenesis. However, the underlying mechanism remains elusive. METHODS: Whole-exome sequencing was performed to identify the mutations. Expression plasmids were constructed and cell culture and immune-biochemical assays were used to examine the effects of the mutation. RESULTS: We reported a female patient with classical symptoms of WWS and discovered a novel nonsense heterozygous mutation (p.R67X; c.199C>T) in ZC4H2 gene in the patient but not in her parents. The mutation resulted in a 66 amino-acid truncated ZC4H2 protein. The mutation is located in the key helix domain and it altered the subcellular locations of the mutant ZC4H2 protein. X-chromosome inactivation (XCI) pattern analysis revealed that the XCI ratio of the proband was 22:78. CONCLUSION: Female heterozygous carriers with nonsense mutation with a truncated ZC4H2 protein could lead to the pathogenesis of Wieacker-Wolff syndrome and our study provides a potential new target for the disease treatment.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2019) conducted a case report in Wieacker-Wolff Syndrome (n=1). ZC4H2 nonsense mutation (p.R67X; c.199C>T) was evaluated on Identification of pathogenic mutation and its functional effect. A novel de novo nonsense mutation (p.R67X) in the ZC4H2 gene was identified in a female patient with Wieacker-Wolff syndrome, resulting in a truncated protein with altered subcellular localization.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: